Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | ESR1 | P03372 | 3/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL192853 | 0.88 | KIF11 (0.48) | ALDH1A1CYP3A4MAPK1MAPTKMT2A | |
| SCHEMBL14594552 | 0.82 | ESR1 (0.45) | ALDH1A1ESR1ESR2CYP3A4MAPK1 | |
| SCHEMBL4926591 | 0.81 | TSHR (0.50) | ALDH1A1CYP3A4MAPK1MAPTKMT2A | |
| SCHEMBL29148200 | 0.80 | TAAR1 (0.40) | ALDH1A1ESR1ESR2CYP3A4MAPK1 | |
| SCHEMBL28102219 | 0.79 | ALDH1A1 (0.44) | ALDH1A1ESR1ESR2CYP3A4MAPK1 | |
| SCHEMBL4969374 | 0.79 | TSHR (0.55) | ALDH1A1MAPK1MAPTKMT2AMEN1 | |
| SCHEMBL2121346 | 0.79 | ESR1 (0.44) | ALDH1A1ESR1ESR2CYP3A4MAPK1 | |
| SCHEMBL27948396 | 0.79 | ALDH1A1 (0.44) | ALDH1A1ESR1ESR2CYP3A4MAPK1 | |
| SCHEMBL3160077 | 0.77 | CES2 (0.44) | ALDH1A1TSHR | |
| SCHEMBL1806495 | 0.77 | MEN1 (0.52) | CYP3A4MAPK1MAPTKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 304 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240010679-A1 | ANTINOCICEPTIVE COMPOUNDS AND USES THEREOF | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2024-01-11 | — | — | US | claimed |
| CN-117374275-A | Walnut shell hard carbon anode material and preparation method and application thereof | 常州烯源谷新材料科技有限公司 | 2024-01-09 | — | — | CN | claimed |
| WO-2022107049-A1 | ANTINOCICEPTIVE COMPOUNDS AND USES THEREOF | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2022-05-27 | — | — | WO | claimed |
| CN-109438205-B | Synthesis method of 2-methyl-2, 3-diaryl propionaldehyde derivative | 西北大学 | 2021-11-12 | — | — | CN | claimed |
| CN-109400438-B | Synthesis method of 9, 10-disubstituted phenanthrene compound | 西北大学 | 2021-07-02 | — | — | CN | claimed |
| CN-109385889-B | Antibacterial and anti-radiation fabric | 银维康新材料科技(珠海)有限公司 | 2021-05-07 | — | — | CN | claimed |
| CN-108923064-B | Solid polymer electrolyte, preparation method thereof and lithium ion secondary battery | 山西长韩新能源科技有限公司 | 2020-10-02 | — | — | CN | claimed |
| EP-3713921-A1 | HYDROLYTICALLY LABILE HETEROCYCLES OF ODORIFEROUS KETONES OR ODORIFEROUS ALDEHYDES | Henkel AG & Co. KGaA (DE) | 2020-09-30 | — | — | EP | claimed |
| US-8680040-B2 | 1-aza-3,7-dioxabicyclo[3,3,0]octane compounds and monocyclic oxazolidines as pro-fragrances | HENKEL AG & CO. KGAA (DE) | 2014-03-25 | — | — | US | claimed |
| US-7968605-B2 | Methods for treating inflammatory disease by administering aldehydes and derivatives thereof | ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. (PT) | 2011-06-28 | — | — | US | claimed |
| EP-2099439-A2 | METHODS FOR TREATING INFLAMMATORY DISEASE BY ADMINISTERING ALDEHYDES AND DERIVATIVES THEREOF | ALFAMA - INVESTIGAÇÃO E DESENVOLVIMENTO DE PRODUTO (PT) | 2009-09-16 | — | — | EP | claimed |
| US-7439384-B2 | Catalytic polymerization of vinyl chloride with bases with peroxy compounds | ATOFINA (FR) | 2008-10-21 | — | — | US | claimed |
| WO-2008069688-A2 | METHODS FOR TREATING INFLAMMATORY DISEASE BY ADMINISTERING ALDEHYDES AND DERIVATIVES THEREOF | ALFAMA - INVESTIGAÇÃO E DESENVOLVIMENTO DE PRODUTOS FARMACÊUTICOS LDA (PT) | 2008-06-12 | — | — | WO | claimed |
| US-20080026984-A1 | Methods for treating inflammatory disease by administering aldehydes and derivatives thereof | ALFAMA - INVESTIGACAO E DESENVOLVIMENTO DE PRODUCTOS FARMACEUTICOS LDA (PT) | 2008-01-31 | — | — | US | claimed |
| US-20070219120-A1 | Methods for treating inflammatory disease by administering aldehydes and derivatives thereof | ALFAMA - INVESTIGACAO E DESENVOLVIMENTO DE PRODUCTOS FARMACEUTICOS LDA (PT) | 2007-09-20 | — | — | US | claimed |
| EP-1362029-B1 | HYDROXY-PEROXYESTER PREPARATION METHOD | ARKEMA (FR) | 2005-09-14 | — | — | EP | claimed |
| US-20040176632-A1 | Catalytic polymerization of vinyl chloride with bases with peroxy compounds | ATOFINA (FR) | 2004-09-09 | — | — | US | claimed |
| US-12622880-B2 | Therapeutic system for the topical, transdermal and transcutaneous application of carbon monoxide | JULIUS-MAXIMILIANS-UNIVERSITAET WUERZBURG (DE) | 2026-05-12 | — | — | US | disclosed |
| US-4181800-A | ANTIBIOTICS FROM SUBSTITUTED PERHYDRO-S-TRIAZINES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1980-01-01 | — | — | US | disclosed |
| US-4044060-A | PHOSGENE, THIONYL, PHOSPHORUS, ALDEHYDE, KETONE | BAYER AKTIENGESELLSCHAFT (DT) | 1977-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080026984-A1 | Methods for treating inflammatory disease by administering aldehydes and derivatives thereof | MPO, TNF, AOX1 | ALDH1A1 7/4885ESR1 3788/4885ESR2 1583/4885 |
| US-20240010679-A1 | ANTINOCICEPTIVE COMPOUNDS AND USES THEREOF | OPRL1, OPRK1, OPRD1 | ALDH1A1 692/4885ESR1 1504/4885ESR2 734/4885 |
| US-20070219120-A1 | Methods for treating inflammatory disease by administering aldehydes and derivatives thereof | MPO, TNF, AOX1 | ALDH1A1 7/4885ESR1 3788/4885ESR2 1583/4885 |
| US-12622880-B2 | Therapeutic system for the topical, transdermal and transcutaneous application of carbon monoxide | COL2A1, COL1A1, MB | ALDH1A1 3397/4885ESR1 161/4885ESR2 359/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.